Medical Rehabilitation Services Market (By Therapy: Physical Therapy, Cognitive Therapy; By Service; By Application; By End-use) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2023-2032

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Medical Rehabilitation Market 

5.1. COVID-19 Landscape: Medical Rehabilitation Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Medical Rehabilitation Market, By Therapy

8.1. Medical Rehabilitation Market, by Therapy, 2023-2032

8.1.1. Occupational Therapy

8.1.1.1. Market Revenue and Forecast (2020-2032)

8.1.2. Speech and Language Therapy

8.1.2.1. Market Revenue and Forecast (2020-2032)

8.1.3. Physical Therapy

8.1.3.1. Market Revenue and Forecast (2020-2032)

8.1.4. Cognitive Therapy

8.1.4.1. Market Revenue and Forecast (2020-2032)

8.1.5. Others

8.1.5.1. Market Revenue and Forecast (2020-2032)

Chapter 9. Global Medical Rehabilitation Market, By Service

9.1. Medical Rehabilitation Market, by Service, 2023-2032

9.1.1. Outpatient Rehabilitation Services

9.1.1.1. Market Revenue and Forecast (2020-2032)

9.1.2. Inpatient Rehabilitation Services

9.1.2.1. Market Revenue and Forecast (2020-2032)

Chapter 10. Global Medical Rehabilitation Market, By Application 

10.1. Medical Rehabilitation Market, by Application, 2023-2032

10.1.1. Orthopedic

10.1.1.1. Market Revenue and Forecast (2020-2032)

10.1.2. Neurological

10.1.2.1. Market Revenue and Forecast (2020-2032)

10.1.3. Cardiologic

10.1.3.1. Market Revenue and Forecast (2020-2032)

10.1.4. Pulmonary

10.1.4.1. Market Revenue and Forecast (2020-2032)

10.1.5. Sports Related Injuries

10.1.5.1. Market Revenue and Forecast (2020-2032)

10.1.6. Others

10.1.6.1. Market Revenue and Forecast (2020-2032)

Chapter 11. Global Medical Rehabilitation Market, By End-use 

11.1. Medical Rehabilitation Market, by End-use, 2023-2032

11.1.1. Hospitals and Clinics

11.1.1.1. Market Revenue and Forecast (2020-2032)

11.1.2. Rehab Centers

11.1.2.1. Market Revenue and Forecast (2020-2032)

11.1.3. Homecare Settings

11.1.3.1. Market Revenue and Forecast (2020-2032)

11.1.4. Physiotherapy Centers

11.1.4.1. Market Revenue and Forecast (2020-2032)

Chapter 12. Global Medical Rehabilitation Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Therapy (2020-2032)

12.1.2. Market Revenue and Forecast, by Service (2020-2032)

12.1.3. Market Revenue and Forecast, by Application (2020-2032)

12.1.4. Market Revenue and Forecast, by End-use (2020-2032)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Therapy (2020-2032)

12.1.5.2. Market Revenue and Forecast, by Service (2020-2032)

12.1.5.3. Market Revenue and Forecast, by Application (2020-2032)

12.1.5.4. Market Revenue and Forecast, by End-use (2020-2032)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Therapy (2020-2032)

12.1.6.2. Market Revenue and Forecast, by Service (2020-2032)

12.1.6.3. Market Revenue and Forecast, by Application (2020-2032)

12.1.6.4. Market Revenue and Forecast, by End-use (2020-2032)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Therapy (2020-2032)

12.2.2. Market Revenue and Forecast, by Service (2020-2032)

12.2.3. Market Revenue and Forecast, by Application (2020-2032)

12.2.4. Market Revenue and Forecast, by End-use (2020-2032)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Therapy (2020-2032)

12.2.5.2. Market Revenue and Forecast, by Service (2020-2032)

12.2.5.3. Market Revenue and Forecast, by Application (2020-2032)

12.2.5.4. Market Revenue and Forecast, by End-use (2020-2032)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Therapy (2020-2032)

12.2.6.2. Market Revenue and Forecast, by Service (2020-2032)

12.2.6.3. Market Revenue and Forecast, by Application (2020-2032)

12.2.6.4. Market Revenue and Forecast, by End-use (2020-2032)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Therapy (2020-2032)

12.2.7.2. Market Revenue and Forecast, by Service (2020-2032)

12.2.7.3. Market Revenue and Forecast, by Application (2020-2032)

12.2.7.4. Market Revenue and Forecast, by End-use (2020-2032)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Therapy (2020-2032)

12.2.8.2. Market Revenue and Forecast, by Service (2020-2032)

12.2.8.3. Market Revenue and Forecast, by Application (2020-2032)

12.2.8.4. Market Revenue and Forecast, by End-use (2020-2032)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Therapy (2020-2032)

12.3.2. Market Revenue and Forecast, by Service (2020-2032)

12.3.3. Market Revenue and Forecast, by Application (2020-2032)

12.3.4. Market Revenue and Forecast, by End-use (2020-2032)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Therapy (2020-2032)

12.3.5.2. Market Revenue and Forecast, by Service (2020-2032)

12.3.5.3. Market Revenue and Forecast, by Application (2020-2032)

12.3.5.4. Market Revenue and Forecast, by End-use (2020-2032)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Therapy (2020-2032)

12.3.6.2. Market Revenue and Forecast, by Service (2020-2032)

12.3.6.3. Market Revenue and Forecast, by Application (2020-2032)

12.3.6.4. Market Revenue and Forecast, by End-use (2020-2032)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Therapy (2020-2032)

12.3.7.2. Market Revenue and Forecast, by Service (2020-2032)

12.3.7.3. Market Revenue and Forecast, by Application (2020-2032)

12.3.7.4. Market Revenue and Forecast, by End-use (2020-2032)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Therapy (2020-2032)

12.3.8.2. Market Revenue and Forecast, by Service (2020-2032)

12.3.8.3. Market Revenue and Forecast, by Application (2020-2032)

12.3.8.4. Market Revenue and Forecast, by End-use (2020-2032)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Therapy (2020-2032)

12.4.2. Market Revenue and Forecast, by Service (2020-2032)

12.4.3. Market Revenue and Forecast, by Application (2020-2032)

12.4.4. Market Revenue and Forecast, by End-use (2020-2032)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Therapy (2020-2032)

12.4.5.2. Market Revenue and Forecast, by Service (2020-2032)

12.4.5.3. Market Revenue and Forecast, by Application (2020-2032)

12.4.5.4. Market Revenue and Forecast, by End-use (2020-2032)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Therapy (2020-2032)

12.4.6.2. Market Revenue and Forecast, by Service (2020-2032)

12.4.6.3. Market Revenue and Forecast, by Application (2020-2032)

12.4.6.4. Market Revenue and Forecast, by End-use (2020-2032)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Therapy (2020-2032)

12.4.7.2. Market Revenue and Forecast, by Service (2020-2032)

12.4.7.3. Market Revenue and Forecast, by Application (2020-2032)

12.4.7.4. Market Revenue and Forecast, by End-use (2020-2032)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Therapy (2020-2032)

12.4.8.2. Market Revenue and Forecast, by Service (2020-2032)

12.4.8.3. Market Revenue and Forecast, by Application (2020-2032)

12.4.8.4. Market Revenue and Forecast, by End-use (2020-2032)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Therapy (2020-2032)

12.5.2. Market Revenue and Forecast, by Service (2020-2032)

12.5.3. Market Revenue and Forecast, by Application (2020-2032)

12.5.4. Market Revenue and Forecast, by End-use (2020-2032)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Therapy (2020-2032)

12.5.5.2. Market Revenue and Forecast, by Service (2020-2032)

12.5.5.3. Market Revenue and Forecast, by Application (2020-2032)

12.5.5.4. Market Revenue and Forecast, by End-use (2020-2032)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Therapy (2020-2032)

12.5.6.2. Market Revenue and Forecast, by Service (2020-2032)

12.5.6.3. Market Revenue and Forecast, by Application (2020-2032)

12.5.6.4. Market Revenue and Forecast, by End-use (2020-2032)

Chapter 13. Company Profiles

13.1. Shirley Ryan AbilityLab

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Prism Medical

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Icahn School of Medicine at Mount Sinai

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Paradigm Healthcare

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. The University of Chicago Medical Center

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. MindMaze Healthcare

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Lifespan Physical Therapy Services

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. SuVitas

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. nMotion Physical Therapy

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Therapy Solutions for Kids

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms